Status:
UNKNOWN
Incidence of Malignant and Premalignant Endometrial Polyp in Asymptomatic and Symptomatic Postmenopausal Women
Lead Sponsor:
Arie Lissak, MD
Conditions:
Endometrial Polyp.
Malignant and Pre-malignant Changes in the Polyp
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The prevalence of endometrial polyp is 24% in the general population but is much higher in postmenopausal women. The incidence of malignant or pre-malignant findings in endometrial polyps ranges from ...
Detailed Description
Endometrial polyp is a common finding in postmenopausal women. The prevalence of endometrial polyps is 24% in the general population, but is much higher in postmenopausal in compare to premenopausal w...
Eligibility Criteria
Inclusion
- Postmenopausal symptomatic women with Ultrasonographic or other imaging findings that correlates with endometrial polyp.
- Postmenopausal asymptomatic women with Ultrasonographic or other imaging findings that correlates with endometrial polyp
- Women who can read and understand and sign consent form
- Women between 18 and 80 years of age.
- ASA (American Society of Anesthesiologist) physical status grade 1-3
Exclusion
- Histological Evidence of endometrial malignancy
- Asymptomatic woman with endometrial polyps smaller than 4 mm with no risk factors that fulfills one of the following conditions:
- Immune depressed or terminal illness.
- Women under anticoagulant treatment that its discontinuation, as a precondition for medical surgical intervention, could endanger their health.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT01203176
Start Date
September 1 2010
End Date
August 1 2014
Last Update
December 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carmel Medical Center
Haifa, Israel